The Current Ratio of Surface Oncology Inc (SURF) is
7.94.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2022-12-31 |
7.94
|
| 2021-12-31 |
7.86
|
| 2020-12-31 |
10.20
|
| 2019-12-31 |
5.59
|
| 2018-12-31 |
6.05
|
| 2017-12-31 |
3.05
|
| 2016-12-31 |
5.75
|
| Ticker |
Name |
Value |
|
CLVS
|
Clovis Oncology Inc
|
1.58
|
|
CNTG
|
Centogene NV
|
1.02
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
OVID
|
Ovid Therapeutics Inc.
|
8.97
|
|
SELB
|
Selecta Biosciences Inc
|
5.91
|
|
ACIU
|
AC Immune AG
|
1.02
|
|
ACOR
|
Acorda Therapeutics Inc
|
0.33
|
|
CTMX
|
CytomX Therapeutics, Inc.
|
3.09
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
ANAB
|
AnaptysBio, Inc.
|
5.61
|
|
XOMA
|
XOMA Royalty Corporation
|
3.37
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
JNCE
|
Jounce Therapeutics Inc
|
8.37
|
|
NXTC
|
NextCure Inc
|
4.14
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
ACET
|
ADICET Bio, Inc.
|
7.47
|
|
AGEN
|
Agenus Inc
|
0.41
|
|
DTIL
|
Precision Biosciences, Inc
|
13.32
|
|
KIN
|
Kindred Biosciences Inc
|
9.07
|
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
2.42
|
|
SQZ
|
SQZ Biotechnologies Co
|
3.12
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
SESN
|
Sesen Bio Inc
|
17.77
|
|
SYRS
|
Syros Pharmaceuticals Inc
|
3.95
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
VYGR
|
Voyager Therapeutics, Inc.
|
7.64
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
ABUS
|
Arbutus Biopharma Corp
|
15.73
|
|
ASMB
|
Assembly Biosciences Inc
|
5.22
|
|
BIOQ
|
Bioqual Inc
|
3.72
|
|
PIRS
|
Pieris Pharmaceuticals Inc
|
3.24
|
|
PRQR
|
ProQR Therapeutics NV
|
3.09
|
|
SPRO
|
Spero Therapeutics, Inc.
|
7.59
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
XBIT
|
XBiotech Inc
|
16.01
|
|
APVO
|
Aptevo Therapeutics Inc
|
3.81
|